|
|
| | 5-Chloro-3-nitropyrazolo[1,5-a]pyriMidine Basic information |
| Product Name: | 5-Chloro-3-nitropyrazolo[1,5-a]pyriMidine | | Synonyms: | 5-Chloro-3-nitropyrazolo[1,5-a]pyriMidine;Pyrazolo[1,5-a]pyrimidine, 5-chloro-3-nitro-;5-Chloro-3-nitropyrazolo[1,5-a]pyriMidin;5-Chloro-3-nitropyrazolo[...;Larotrectinib Impurity 1（Larotrectinib CNPP Impurity）;arotrectinib CNPP Impurity;Larotrectinib CNPP Impurity;5-chloro-3-nitropyrazolo[1,5-a]pyrimidine (Nitro ) | | CAS: | 1363380-51-1 | | MF: | C6H3ClN4O2 | | MW: | 198.57 | | EINECS: | 251-228-4 | | Product Categories: | | | Mol File: | 1363380-51-1.mol | ![5-Chloro-3-nitropyrazolo[1,5-a]pyriMidine Structure](CAS/GIF/1363380-51-1.gif) |
| | 5-Chloro-3-nitropyrazolo[1,5-a]pyriMidine Chemical Properties |
| Melting point | 163 - 165°C | | density | 1.85±0.1 g/cm3(Predicted) | | storage temp. | under inert gas (nitrogen or Argon) at 2-8°C | | solubility | Chloroform (Slightly, Heated), DMSO (Slightly) | | form | Solid | | pka | -3.59±0.40(Predicted) | | color | Purple | | InChI | InChI=1S/C6H3ClN4O2/c7-5-1-2-10-6(9-5)4(3-8-10)11(12)13/h1-3H | | InChIKey | VYEUPRYCLWAOMU-UHFFFAOYSA-N | | SMILES | C12=C([N+]([O-])=O)C=NN1C=CC(Cl)=N2 |
| | 5-Chloro-3-nitropyrazolo[1,5-a]pyriMidine Usage And Synthesis |
| Chemical Properties |
5-Chloro-3-nitropyrazolo[1,5-a]pyriMidine is a Pale-yellow to Yelow-brown Solid, it can undergo electrophilic and nucleophilic substitution reactions.
| | Uses | 5-Chloro-3-nitro-pyrazolo[1,5-a]pyrimidine is used in the preparation of (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide, a tyrosine kinase (TRK) inhibitor for treating cancer. | | Health Hazard |
5-Chloro-3-nitropyrazolo[1,5-a]pyriMidine has acute oral toxicity, it causes skin corrosion/irritation and serious eye damage/eye irritation.
|
| | 5-Chloro-3-nitropyrazolo[1,5-a]pyriMidine Preparation Products And Raw materials |
|